Unnamed: 0,title,date,stock,sentiment
1150285.0,Stocks That Hit 52-Week Highs On Friday,2020-05-29 10:36:00-04:00,SLP,neutral
1150286.0,65 Biggest Movers From Yesterday,2020-05-29 05:35:00-04:00,SLP,neutral
1150287.0,48 Stocks Moving In Thursday's Mid-Day Session,2020-05-28 12:28:00-04:00,SLP,neutral
1150288.0,Stocks That Hit 52-Week Highs On Thursday,2020-05-28 10:39:00-04:00,SLP,neutral
1150289.0,Simulations Plus Reports $400K 3-Year Grant By FDA For Development Of Physiologically-Based Phamacokinetics/Pharmacodynamics Approaches To Support Interspecies Translation For Ocular Drug Delivery In GastroPlus,2020-05-28 08:33:00-04:00,SLP,positive
1150290.0,Simulations Plus Receives New Grant Award From FDA For Ophthalmic Drug,2020-05-28 08:31:00-04:00,SLP,positive
1150291.0,Simulation Plus Reports FDA Renews Software Licenses For Its DILIsym Services Unit,2020-05-06 08:34:00-04:00,SLP,neutral
1150292.0,Stocks That Hit 52-Week Highs On Friday,2020-04-24 10:33:00-04:00,SLP,neutral
1150293.0,"Simulations Plus Q2 EPS $0.120 Misses $0.140 Estimate, Sales $10.300M Beat $9.860M Estimate",2020-04-09 16:35:00-04:00,SLP,negative
1150294.0,"Earnings Scheduled For April 9, 2020",2020-04-09 04:42:00-04:00,SLP,neutral
1150295.0,"Simulations Plus Reports New Collaboration Deal With Large Pharma Co. To Advance Its ADMET Predictor Machine Learning Software, No Terms Disclosed",2020-04-07 08:31:00-04:00,SLP,negative
1150296.0,"Simulations Plus Reports Purchase Of Lixoft For $16.5M In Cash, Stock",2020-04-02 08:43:00-04:00,SLP,neutral
1150297.0,Simulations Plus Reports Establishment Of StratgiesPlus Coronavirus ACT Program 'to speed consulting assistance to any organization involved in coronavirus research',2020-03-26 13:47:00-04:00,SLP,neutral
1150298.0,55 Biggest Movers From Friday,2020-01-13 05:17:00-05:00,SLP,neutral
1150299.0,40 Stocks Moving In Friday's Mid-Day Session,2020-01-10 12:29:00-05:00,SLP,neutral
1150300.0,33 Stocks Moving in Friday's Pre-Market Session,2020-01-10 07:26:00-05:00,SLP,neutral
1150301.0,"Simulations Plus Q1 EPS $0.11 Beats $0.1 Estimate, Sales $9.401M Beat $8.61M Estimate",2020-01-09 16:09:00-05:00,SLP,neutral
1150302.0,"Earnings Scheduled For January 9, 2020",2020-01-09 04:44:00-05:00,SLP,neutral
1150303.0,"Benzinga's Top Upgrades, Downgrades For January 6, 2020",2020-01-06 12:42:00-05:00,SLP,positive
1150304.0,"Craig-Hallum Initiates Coverage On Simulations Plus with Buy Rating, Announces $40 Price Target",2020-01-06 09:45:00-05:00,SLP,neutral
1150305.0,"Simulations Plus Reports Partnership, New Funded Collaboration With Large Pharma Co. To Enhance PKPlus Software, No Terms Disclosed",2019-11-21 08:40:00-05:00,SLP,negative
1150306.0,Simulations Plus Partners With Pharmaceutical Company To 'Enhance the Mechanistic Oral Absorption Model' In GastroPlus,2019-11-14 08:45:00-05:00,SLP,neutral
1150307.0,"Simulations Plus Q4 EPS $0.11 Up From $0.07 YoY, Sales $8.026M Beat $7.51M Estimate",2019-11-13 16:23:00-05:00,SLP,neutral
1150308.0,84 Biggest Movers From Yesterday,2019-09-10 05:01:00-04:00,SLP,neutral
1150309.0,44 Stocks Moving In Monday's Mid-Day Session,2019-09-09 12:21:00-04:00,SLP,neutral
1150310.0,30 Stocks Moving in Monday's Pre-Market Session,2019-09-09 07:57:00-04:00,SLP,neutral
1150311.0,82 Biggest Movers From Friday,2019-08-05 05:40:00-04:00,SLP,neutral
1150312.0,60 Stocks Moving In Friday's Mid-Day Session,2019-08-02 13:43:00-04:00,SLP,neutral
1150313.0,"Jim Cramer Advises His Viewers On Colgate-Palmolive, Banco Santander And More",2019-08-01 11:07:00-04:00,SLP,neutral
1150314.0,New Equities that Broke Through 52-Week Highs Monday Morning,2019-07-29 10:13:00-04:00,SLP,negative
1150315.0,Companies That Achieved 52-Week Highs Friday,2019-07-26 15:37:00-04:00,SLP,neutral
1150316.0,"Top 10 Most Overbought Stocks Via Benzinga Pro's Screener Tool For Fri., July 26, 2019",2019-07-26 14:22:00-04:00,SLP,positive
1150317.0,58 Biggest Movers From Yesterday,2019-07-19 05:02:00-04:00,SLP,neutral
1150318.0,42 Stocks Moving In Thursday's Mid-Day Session,2019-07-18 12:57:00-04:00,SLP,neutral
1150319.0,Simulations Plus Enters Into New Research Collaboration Agreement With The FDA,2019-07-16 08:33:00-04:00,SLP,positive
1150320.0,55 Biggest Movers From Yesterday,2019-07-12 05:18:00-04:00,SLP,neutral
1150321.0,48 Stocks Moving In Thursday's Mid-Day Session,2019-07-11 12:50:00-04:00,SLP,neutral
1150322.0,Simulations Plus shares are trading higher after the company reported better-than-expected Q3 EPS and sales results.,2019-07-11 11:08:00-04:00,SLP,positive
1150323.0,35 Stocks Moving In Thursday's Pre-Market Session,2019-07-11 08:21:00-04:00,SLP,neutral
1150324.0,Simulations Plus shares are trading higher after the company reported better-than-expected Q3 EPS and sales results.,2019-07-10 16:19:00-04:00,SLP,positive
1150325.0,"Simulations Plus Q3 EPS $0.16 Beats $0.14 Estimate, Sales $9.937M Beat $9.84M Estimate",2019-07-10 16:14:00-04:00,SLP,neutral
1150326.0,"Earnings Scheduled For July 10, 2019",2019-07-10 04:08:00-04:00,SLP,neutral
1150327.0,"Simulations Plus Reports Received Order From FDA For 15-User License To ADMET Predictor Software Suite, No Terms Disclosed",2019-04-30 08:35:00-04:00,SLP,negative
1150328.0,46 Biggest Movers From Yesterday,2019-04-11 05:09:00-04:00,SLP,neutral
1150329.0,33 Stocks Moving In Wednesday's Mid-Day Session,2019-04-10 13:17:00-04:00,SLP,neutral
1150330.0,Simulations Plus shares trading higher following strong Q2 results.,2019-04-10 13:05:00-04:00,SLP,positive
1150331.0,26 Stocks Moving In Wednesday's Pre-Market Session,2019-04-10 08:05:00-04:00,SLP,neutral
1150332.0,"A Peek Into The Markets: US Stock Futures Climb Ahead Of CPI, Fed Minutes",2019-04-10 07:19:00-04:00,SLP,neutral
1150333.0,"6 Stocks To Watch For April 10, 2019",2019-04-10 06:03:00-04:00,SLP,neutral
1150334.0,6 Stocks Moving In Tuesday's After-Hours Session,2019-04-09 16:43:00-04:00,SLP,neutral
1150335.0,Simulations Plus shares trading higher following better-than-expected Q2 results.,2019-04-09 16:33:00-04:00,SLP,positive
1150336.0,"Simulations Plus Q2 EPS $0.12 Beats $0.1 Estimate, Sales $8.472M Beat $8.32M Estimate",2019-04-09 16:07:00-04:00,SLP,neutral
1150337.0,"Earnings Scheduled For April 9, 2019",2019-04-09 06:11:00-04:00,SLP,neutral
1150338.0,"Stocks Trading Ex Dividend For Thurs., Jan. 24, 2019",2019-01-24 10:04:00-05:00,SLP,neutral
1150339.0,"DILIsym, A Simulations Plus Company, Wins $1.5M Phase II NIH Grant For Its RENAsym Kidney Injury Software",2019-01-17 08:40:00-05:00,SLP,positive
1150340.0,DILIsym Services Wins a $1.5M Grant,2019-01-17 08:30:00-05:00,SLP,positive
1150341.0,28 Stocks Moving In Thursday's Pre-Market Session,2019-01-10 08:31:00-05:00,SLP,neutral
1150342.0,"7 Stocks To Watch For January 10, 2019",2019-01-10 04:32:00-05:00,SLP,neutral
1150343.0,"Simulations Plus Q1 EPS $0.09 Misses $0.12 Estimate, Sales $7.54M Beat $7.53M Estimate",2019-01-09 16:06:00-05:00,SLP,negative
1150344.0,"Earnings Scheduled For January 9, 2019",2019-01-09 04:19:00-05:00,SLP,neutral
1150345.0,"Simulations Plus, Inc. Q4 EPS $0.07 Up From $0.06 YoY, Sales $6.7M Beat $5.99M Estimate",2018-11-14 16:41:00-05:00,SLP,neutral
1150346.0,"Stocks Trading Ex Dividend For Wed., Oct. 31, 2018",2018-10-31 09:47:00-04:00,SLP,neutral
1150347.0,"Stocks That Will Be Trading Ex Dividend Wed., Oct. 31, 2018",2018-10-30 15:44:00-04:00,SLP,neutral
1150348.0,Simulations Plus Receives $250K/Yr Grant Award From The FDA,2018-09-12 08:32:00-04:00,SLP,positive
1150349.0,UPDATE: Simulations Plus Says Funded Research Collaboration With FDA Extended By 1 Year,2018-09-05 08:33:00-04:00,SLP,neutral
1150350.0,Simulations Plus Reports Extension Of Funded Research Collab With FDA,2018-09-05 08:32:00-04:00,SLP,neutral
1150351.0,"Stocks Trading Ex Dividend For Wed., Jul. 25, 2018",2018-07-25 10:18:00-04:00,SLP,neutral
1150352.0,Simulations Plus Subsidiary DILIsym Awarded Grant for up to $1.7M For Model Development,2018-07-23 08:34:00-04:00,SLP,positive
1150353.0,Simulations Plus Reports Subsidiary DILIsym Won Grant For Up To $1.7M For Model Development,2018-07-23 08:30:00-04:00,SLP,positive
1150354.0,44 Biggest Movers From Yesterday,2018-07-12 04:00:00-04:00,SLP,neutral
1150355.0,Mid-Afternoon Market Update: Dow Down Over 200 Points; Achieve Life Sciences Shares Spike Higher,2018-07-11 14:32:00-04:00,SLP,positive
1150356.0,Mid-Day Market Update: Crude Oil Down Over 2%; Simulations Plus Shares Plunge,2018-07-11 12:50:00-04:00,SLP,negative
1150357.0,38 Stocks Moving In Wednesday's Mid-Day Session,2018-07-11 12:35:00-04:00,SLP,neutral
1150358.0,Mid-Morning Market Update: Markets Open Lower; Fastenal Profit Tops Views,2018-07-11 10:14:00-04:00,SLP,positive
1150359.0,"Simulations Plus Q3 EPS $0.13, Inline, Sales $8.553M Beat $8.09M Estimate",2018-07-10 16:02:00-04:00,SLP,neutral
1150360.0,Simulations Plus Shares Tick Slightly Lower As Traders Circulate Seeking Alpha Article 'Reality About To Set In For Simulations Plus Investors; Up To 70% Decline Possible',2018-07-10 12:09:00-04:00,SLP,positive
1150361.0,"Earnings Scheduled For July 10, 2018",2018-07-10 04:22:00-04:00,SLP,neutral
1150362.0,Simulations Plus Names Shawn O'Connor CEO,2018-06-26 08:30:00-04:00,SLP,neutral
1150363.0,Simulations Plus Co. DILIsym Services Says US FDA Procures DILIsym Software License Package,2018-05-08 08:32:00-04:00,SLP,neutral
1150364.0,25 Stocks Moving In Tuesday's Pre-Market Session,2018-04-10 07:53:00-04:00,SLP,neutral
1150365.0,"10 Stocks To Watch For April 10, 2018",2018-04-10 04:01:00-04:00,SLP,neutral
1150366.0,"Simulations Plus Reports Q2 Adj. EPS $0.20 vs $0.10 Est., Sales $7.4M vs $7.15M Est.",2018-04-09 16:05:00-04:00,SLP,neutral
1150367.0,"5 Stocks To Watch For April 9, 2018",2018-04-09 04:17:00-04:00,SLP,neutral
1150368.0,"Earnings Scheduled For April 9, 2018",2018-04-09 04:07:00-04:00,SLP,neutral
1150369.0,"Simulations Plus Reports Q1 EPS $0.10 vs $0.09 Est., Sales $7.1M vs $6.57M Est.",2018-01-09 16:02:00-05:00,SLP,neutral
1150370.0,"Earnings Scheduled For January 9, 2018",2018-01-09 04:22:00-05:00,SLP,neutral
1150371.0,"Simulations Plus Reports Q4 EPS $0.06 vs $0.05 Est., Revenue $6.3M vs $4M In Same Qtr. Last Year",2017-11-14 16:27:00-05:00,SLP,neutral
1150372.0,"Simulations Plus Reports Prelim. Q4 Results: Sales $6.3M vs $5M Est., Added 25 New Software Customers",2017-10-03 08:35:00-04:00,SLP,neutral
1150373.0,12 Biggest Mid-Day Gainers For Tuesday,2017-07-11 12:24:00-04:00,SLP,neutral
1150374.0,Simulations Plus Reports Q3 Diluted EPS $0.12 vs. $0.11 Est.,2017-07-10 16:09:00-04:00,SLP,neutral
1150375.0,"Earnings Scheduled For July 10, 2017",2017-07-10 04:38:00-04:00,SLP,neutral
1150376.0,Simulations Plus Reports Prelim. Q3 Sales $6.69M vs $6.5M Est.; Prelim. 9-Month Sales $17.82M,2017-06-15 08:32:00-04:00,SLP,neutral
1150377.0,Simulations Plus Reports Will Buy DILIsym Services for $10M,2017-05-01 08:35:00-04:00,SLP,neutral
1150378.0,"Simulations Plus Reports Establishment of Distribution Channel in India, Electrolab",2017-04-20 08:38:00-04:00,SLP,neutral
1150379.0,"Simulations Plus Reports Q2 EPS $0.07 vs $0.08 Est., Sales $5.71M vs $5.54M Est.",2017-04-10 16:01:00-04:00,SLP,neutral
1150380.0,"6 Stocks To Watch For April 10, 2017",2017-04-10 06:48:00-04:00,SLP,neutral
1150381.0,Simulations Plus Reports Finalization of Distributor Deal with Quantum Bio Solutions,2017-04-06 08:34:00-04:00,SLP,positive
1150382.0,Simulations Plus Reports Q2 Prelim. Q2 Sales $5.64M vs. $5.54M Est.,2017-03-13 08:31:00-04:00,SLP,neutral
1150383.0,"Earnings Scheduled For January 9, 2017",2017-01-09 04:45:00-05:00,SLP,neutral
1150384.0,Simulations Plus Reports Prelim. Q1 Rev. $5.36M,2016-12-08 08:31:00-05:00,SLP,neutral
1150385.0,Mid-Morning Market Update: Markets Open Higher; Symantec To Acquire Lifelock,2016-11-21 10:22:00-05:00,SLP,neutral
1150386.0,Mid-Afternoon Market Update: Marvell Gains On Earnings Beat;  Hibbett Shares Plummet,2016-11-18 14:37:00-05:00,SLP,positive
1150387.0,Mid-Day Market Update: Abercrombie & Fitch Drops After Downbeat Earnings; Synutra Shares Spike Higher,2016-11-18 12:16:00-05:00,SLP,positive
1150388.0,Mid-Morning Market Update: Markets Mostly Flat; Foot Locker Profit Beats Estimates,2016-11-18 10:04:00-05:00,SLP,positive
1150389.0,"Simulations Plus Reports Q4 EPS $0.04 vs. Est. $0.04, Rev. $3.96M vs. Est. $4.02M",2016-11-11 16:02:00-05:00,SLP,neutral
1150390.0,"Earnings Scheduled For November 11, 2016",2016-11-11 04:11:00-05:00,SLP,neutral
1150391.0,"10 Notable Stocks Trading Ex-Dividend Tuesday, November 8",2016-11-07 11:42:00-05:00,SLP,neutral
1150392.0,Simulations Plus Reports  Prelim. Q4 Rev. $2.6M vs. Est. $4.02M,2016-09-12 08:31:00-04:00,SLP,neutral
1150393.0,"Notable Stocks Trading Ex-Dividend Tuesday, August 9",2016-08-08 13:34:00-04:00,SLP,neutral
1150394.0,Sun Life Financial to Acquire FWD Hong Kong Pension Business,2016-08-03 06:48:00-04:00,SLP,neutral
1150395.0,The Market In 5 Minutes: Record-Setting Week Coming To A Close,2016-07-15 08:54:00-04:00,SLP,neutral
1150396.0,"Simulations Plus Reports Q3 EPS $0.11 vs. Est. $0.12, Rev. $6.01M vs. Est. $6.57M",2016-07-14 16:01:00-04:00,SLP,neutral
1150397.0,"Earnings Scheduled For July 14, 2016",2016-07-14 04:29:00-04:00,SLP,neutral
1150398.0,Simulations Plus Reports Prelim. Q3 Rev. $5.96M vs. Est. $6.57M,2016-06-07 08:31:00-04:00,SLP,neutral
1150399.0,Simulations Plus Declares $0.05 Cash Dividend,2016-04-22 10:11:00-04:00,SLP,neutral
1150400.0,"Simulations Plus Reports Q2 EPS $0.066 vs $0.07 Est., Sales $5.16M vs $5M Est.",2016-04-13 16:01:00-04:00,SLP,neutral
1150401.0,"Earnings Scheduled For April 13, 2016",2016-04-13 04:36:00-04:00,SLP,neutral
1150402.0,"Simulations Plus Signs 5-year Consulting Agreement with Major Research Foundation, Will Provide $4.7M Over 5 Year Contract",2016-04-06 08:32:00-04:00,SLP,positive
1150403.0,Simulations Plus Reports Prelim. Q2 Sales $5.04M vs $5M Est.,2016-03-10 08:31:00-05:00,SLP,neutral
1150404.0,"TheStreetSweeper Out On SLP, Lists 11 Reasons Stock Will Deflate",2016-02-22 12:41:00-05:00,SLP,neutral
1150405.0,3 Stocks Making New 52-Week Highs,2016-01-20 13:43:00-05:00,SLP,neutral
1150406.0,Stocks Hitting 52-Week Highs,2016-01-20 10:14:00-05:00,SLP,neutral
1150407.0,Mid-Morning Market Update: Markets Open Lower; Goldman Sachs Q4 Profit Drops,2016-01-20 09:55:00-05:00,SLP,positive
1150408.0,"Simulations Plus Reports Q1 EPS $0.06 vs. Est. $0.06, Rev. $4.84M vs. Est. $4.52M",2016-01-14 16:01:00-05:00,SLP,neutral
1150409.0,"Earnings Scheduled For January 14, 2016",2016-01-14 05:59:00-05:00,SLP,neutral
1150410.0,Stocks Hitting 52-Week Highs,2016-01-13 10:16:00-05:00,SLP,neutral
1150411.0,Benzinga's Volume Movers,2016-01-13 10:14:00-05:00,SLP,neutral
1150412.0,Simulations Plus Reports Prelim. Q3 Sales $4.81M vs $4.52M Est.,2015-12-10 08:31:00-05:00,SLP,neutral
1150413.0,"Simulations Plus Reports Q4 EPS $0.029 vs. Est. $0.02, Rev. $3.71M vs. Est. $3.4M",2015-11-18 16:02:00-05:00,SLP,neutral
1150414.0,"Earnings Scheduled For November 18, 2015",2015-11-18 04:10:00-05:00,SLP,neutral
1150415.0,Simulations Plus Unveils PKPlus,2015-10-15 15:15:00-04:00,SLP,neutral
1150416.0,Stocks Hitting 52-Week Highs,2015-09-22 10:32:00-04:00,SLP,neutral
1150417.0,FDA's Office of New Drug Products Places Order for 50 Additional Licenses to GastroPlus,2015-09-17 08:30:00-04:00,SLP,neutral
1150418.0,"Simulations Plus Reports Prelim. Q4 Sales $3.65M vs $3.4M Est., FY15 Sales $18.26M vs $17.6M Est.",2015-09-10 08:31:00-04:00,SLP,neutral
1150419.0,Simulations Plus Awarded New Cooperative Agreement with FDA,2015-09-03 08:30:00-04:00,SLP,positive
1150420.0,Simulations Plus Reports Extension of Research Deal with National Institute of Environmental Health Sciences,2015-07-21 08:31:00-04:00,SLP,neutral
1150421.0,Mid-Day Market Update: Vince Holding Declines After CEO Resignation; Natural Health Trends Shares Surge,2015-07-14 12:49:00-04:00,SLP,positive
1150422.0,Mid-Morning Market Update: Markets Rise; JPMorgan Earnings Beat Views,2015-07-14 10:21:00-04:00,SLP,neutral
1150423.0,"Simulations Plus Reports Q3 EPS $0.11 Vs Exp $0.09, Sales $5.94M Vs Est $5.56M",2015-07-13 16:02:00-04:00,SLP,neutral
1150424.0,"Earning & Economic Calendar for Monday July 13, 2015",2015-07-13 05:15:00-04:00,SLP,neutral
1150425.0,Simulations Plus Reports Prelim. Q3 Sales $5.94M vs $5.56M Est.,2015-06-09 08:35:00-04:00,SLP,neutral
1150426.0,Simulations Plus Reported Q2 Adj. EPS $0.07,2015-04-14 16:11:00-04:00,SLP,neutral
1150427.0,"Simulations Plus Reports Q2 EPS $0.06 vs. Est. $0.07, Rev. $4.6M vs. Est. $4.6M",2015-04-14 16:02:00-04:00,SLP,neutral
1150428.0,Top 4 Small-Cap Stocks In The Business Software & Services Industry With The Highest ROA,2015-03-20 04:50:00-04:00,SLP,positive
1150429.0,Simulations Plus Reports Prelim Q2 Revenues Of $4.544M,2015-03-10 08:33:00-04:00,SLP,neutral
1150430.0,"Simulations Plus Reports Q1 EPS of $0.05, Up 25% YOY; Revenue of $4.10M vs $3.96M Est",2015-01-12 08:33:00-05:00,SLP,neutral
1150431.0,Simulations Plus Reports Favorable First Quarter FY2015 Preliminary Revenues,2014-12-03 08:37:00-05:00,SLP,positive
1150432.0,Simulations Plus Reports Prelim Q1 Sales $3.96M vs $2.89M Est,2014-12-03 08:31:00-05:00,SLP,neutral
1150433.0,Dow Chemical Licenses Simulations Plus Software to Assist with Toxicology and Environmental Research ,2014-10-27 08:03:00-04:00,SLP,neutral
1150434.0,Top 4 Small-Cap Stocks In The Business Software & Services Industry With The Highest Profit Margin,2014-10-06 05:12:00-04:00,SLP,positive
1150435.0,"Simulations Plus Announces Cooperative Deal with FDA Related to Improving Modeling, Simulation Capabilities for Dosage Forms",2014-09-15 08:00:00-04:00,SLP,positive
1150436.0,"Simulations Plus Closes Deal for Cognigen, Names Dr. Thaddeus Grasela as Pres of Combined Cos.",2014-09-02 14:34:00-04:00,SLP,neutral
1150437.0,"Simulations Plus, Inc. Reports Q3 EPS of $0.08, Inline",2014-07-03 08:01:00-04:00,SLP,neutral
1150438.0,"Earnings Scheduled For July 3, 2014",2014-07-03 05:21:00-04:00,SLP,neutral
1150439.0,"Simulations Plus Announces Termination of Licensing with TSRL, TSRL to Pay $6M",2014-05-19 08:06:00-04:00,SLP,negative
1150440.0,Top 4 NASDAQ Stocks In The Business Software & Services Industry With The Highest Dividend Yield,2014-04-22 05:01:00-04:00,SLP,positive
1150441.0,Simulations Plus Raises Qtr. from $0.04 to $0.05/Share,2014-02-05 08:10:00-05:00,SLP,neutral
1150442.0,"Earnings Scheduled For January 13, 2014",2014-01-13 04:55:00-05:00,SLP,neutral
1150443.0,"Simulations Plus, Inc. Reports Q4 EPS of $0.02, Inline; Revenue of $1.58M vs $1.81M Est",2013-11-19 08:03:00-05:00,SLP,neutral
1150444.0,"Earnings Scheduled For November 19, 2013 ",2013-11-19 04:25:00-05:00,SLP,neutral
1150445.0,U.S. FDA Adds Licenses of GastroPlus Software ,2013-10-15 08:06:00-04:00,SLP,neutral
1150446.0,Simulations Plus Raises Qtr. Dividend from $0.02 to $0.03/Share,2013-07-30 08:13:00-04:00,SLP,neutral
1150447.0,"Salix Pharma Joining S&P MidCap 400, Agree Realty, DXP Enterprises to Join S&P SmallCap 600",2013-07-23 17:16:00-04:00,SLP,positive
1150448.0,Simulations Plus Announces Material Transfer Deal with NIEHS,2013-06-24 08:13:00-04:00,SLP,neutral
1150449.0,Simulations Plus Signs Material Transfer Agreement with National Institute of Environmental Health Sciences ,2013-06-24 08:08:00-04:00,SLP,positive
1150450.0,"Simulations Plus Reports Q3 Prelim. Sales $3.1M, Says Renewals Still Strong at ~95%",2013-06-03 08:09:00-04:00,SLP,positive
1150451.0,Simulations Plus Announces $0.03/Share Qtr. Dividend,2013-04-26 08:07:00-04:00,SLP,neutral
1150452.0,Simulations Plus Reports Q2 EPS $0.06 on Sales $3.12M,2013-04-10 16:02:00-04:00,SLP,neutral
1150453.0,"Earnings Scheduled For April 10, 2013",2013-04-10 04:05:00-04:00,SLP,neutral
1150454.0,"Simulations Plus Reports Prelim. Q1 Sales $3.1M vs $2.98M Est, Says Profitable",2013-03-06 08:06:00-05:00,SLP,positive
1150455.0,"Simulations Plus, Inc. Reports Q1 EPS of $0.40 vs $0.04 Est; Revenue of $2.29M vs $2.29M Est",2013-01-15 08:06:00-05:00,SLP,neutral
1150456.0,Simulations Plus Accelerates Qtr. Dividend Payment of $0.14/Share to Dec. 28th,2012-12-13 08:06:00-05:00,SLP,neutral
1150457.0,Simulations Plus Reports Preliminary Q1 Sales of $2.29M vs $2.6M Est,2012-12-07 08:04:00-05:00,SLP,neutral
1150458.0,Simulations Plus Reports Q4 EPS $0.19; Revenues $9.45M,2012-11-15 08:50:00-05:00,SLP,neutral
1150459.0,Simulations Plus Reports 3rd Quarter Earnings of $0.05,2012-07-12 08:04:00-04:00,SLP,neutral
1150460.0,Simulations Plus Signs Additional Collaboration Agreement   ,2012-06-25 08:03:00-04:00,SLP,positive
1150461.0,Simulations Plus Signs Collaboration Agreement   ,2012-06-13 08:02:00-04:00,SLP,positive
1150462.0,Simulations Plus Reports Preliminary; Revenues Increased To $2.77M  From $2.64M vs $2.91M Est,2012-06-04 08:02:00-04:00,SLP,positive
1150463.0,Simulations Plus Announces Preliminary Success in Malaria Drug Design Project   ,2012-03-15 08:02:00-04:00,SLP,positive
1150464.0,Simulations Plus Buys out Royalty Agreement   ,2012-03-07 08:03:00-05:00,SLP,positive
1150465.0,Simulations Plus Reports FY2012 Preliminary Revenues $2.248M,2011-12-06 08:03:00-05:00,SLP,neutral
1150466.0,Simulations Plus Signs Stock Purchase Agreement for Sale of Words+ Subsidiary   ,2011-11-15 13:15:00-05:00,SLP,positive
1150467.0,Simulations Plus Bid for Assets of Entelos Not Selected   ,2011-09-28 08:03:00-04:00,SLP,positive
1150468.0,Simulations Plus Submits Bid in Chapter 11 Bankruptcy Proceedings for Assets of Entelos  ,2011-09-20 08:00:00-04:00,SLP,positive
1150469.0,Simulations Plus Reports Q4 Preliminary Revenue $2.12M,2011-09-07 08:05:00-04:00,SLP,neutral
1150470.0,Simulations Plus Reports Q3 EPS of $0.07; Revenues $3.44M,2011-07-14 08:03:00-04:00,SLP,neutral
1150471.0,Simulations Plus to Collaborate with FDA to Develop Predictive Toxicity Models ,2011-01-26 15:03:00-05:00,SLP,neutral
1150472.0,Simulations Plus Reports Q1 EPS of $0.03,2011-01-14 08:05:00-05:00,SLP,neutral
1150473.0,Simulations Plus Reports First Quarter FY2011 Financial Results ,2011-01-14 08:04:00-05:00,SLP,neutral
1150474.0,Simulations Plus Reports Preliminary Revenues for First Fiscal Quarter of FY2011,2010-12-02 08:13:00-05:00,SLP,neutral
1150475.0,Simulations Plus Reports Fourth Quarter EPS of $.021,2010-11-30 08:09:00-05:00,SLP,neutral
1150476.0,Simulations Plus Reports Preliminary Q4 Revenues,2010-09-08 08:35:00-04:00,SLP,neutral
